$74.2 Million is the total value of Amia Capital LLP's 6 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 88.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PBR | Buy | PETROLEO BRASILEIRO SA PETROsponsored adr | $19,101,000 | +106.4% | 1,700,900 | +30.8% | 25.76% | +139.5% |
GRFS | Sell | GRIFOLS S Asp adr rep b nvt | $18,239,000 | -18.9% | 989,087 | -23.7% | 24.60% | -5.8% |
LSXMK | LIBERTY MEDIA CORP DEL | $16,002,000 | +31.5% | 367,779 | 0.0% | 21.58% | +52.6% | |
LSXMA | LIBERTY MEDIA CORP DEL | $15,284,000 | +30.2% | 353,877 | 0.0% | 20.61% | +51.1% | |
VALE | Sell | VALE S Asponsored ads | $5,028,000 | -47.2% | 300,000 | -66.7% | 6.78% | -38.7% |
INTC | New | INTEL CORP | $498,000 | – | 10,000 | +100.0% | 0.67% | – |
CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -15,408 | -100.0% | -0.05% | – |
KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -23,154 | -100.0% | -0.13% | – |
WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -14,211 | -100.0% | -0.14% | – |
VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -14,632 | -100.0% | -0.18% | – |
SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -21,018 | -100.0% | -0.23% | – |
MTEM | Exit | MOLECULAR TEMPLATES INC | $0 | – | -18,808 | -100.0% | -0.24% | – |
BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -7,589 | -100.0% | -0.27% | – |
NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -14,301 | -100.0% | -0.28% | – |
SRRK | Exit | SCHOLAR ROCK HLDG CORP | $0 | – | -14,821 | -100.0% | -0.30% | – |
MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -25,111 | -100.0% | -0.41% | – |
CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -4,374 | -100.0% | -0.42% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -15,479 | -100.0% | -0.44% | – |
FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -10,209 | -100.0% | -0.47% | – |
RDUS | Exit | RADIUS HEALTH INC | $0 | – | -38,841 | -100.0% | -0.51% | – |
SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -7,644 | -100.0% | -0.54% | – |
ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -19,972 | -100.0% | -0.60% | – |
MGNX | Exit | MACROGENICS INC | $0 | – | -24,131 | -100.0% | -0.71% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -20,464 | -100.0% | -0.88% | – |
AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -21,740 | -100.0% | -0.88% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -7,061 | -100.0% | -0.94% | – |
MYOK | Exit | MYOKARDIA INC | $0 | – | -6,437 | -100.0% | -1.02% | – |
HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -36,279 | -100.0% | -1.11% | – |
ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -6,937 | -100.0% | -1.17% | – |
MRNA | Exit | MODERNA INC | $0 | – | -17,607 | -100.0% | -1.45% | – |
ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -5,077 | -100.0% | -1.55% | – |
VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -5,026 | -100.0% | -1.59% | – |
INCY | Exit | INCYTE CORP | $0 | – | -15,939 | -100.0% | -1.66% | – |
NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -15,939 | -100.0% | -1.78% | – |
BBL | Exit | BHP GROUP PLCsponsored adr | $0 | – | -39,933 | -100.0% | -1.98% | – |
IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -42,552 | -100.0% | -2.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
PETROLEO BRASILEIRO SA PETRO | 13 | Q4 2022 | 25.8% |
LIBERTY MEDIA CORP DELAWARE | 9 | Q4 2021 | 21.7% |
LIBERTY MEDIA CORP DELAWARE | 9 | Q4 2021 | 21.6% |
GRIFOLS S A | 7 | Q2 2021 | 32.3% |
BHP GROUP PLC | 7 | Q4 2021 | 14.5% |
VALE S A | 6 | Q4 2021 | 11.1% |
ISHARES TR | 5 | Q1 2022 | 8.6% |
UBS GROUP AG REG | 5 | Q2 2023 | 2.3% |
MODERNA INC | 5 | Q3 2021 | 1.4% |
ISHARES TR | 4 | Q3 2023 | 79.7% |
View Amia Capital LLP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-08 |
13F-HR | 2023-08-01 |
13F-HR | 2023-05-09 |
13F-HR | 2023-02-06 |
13F-HR | 2022-11-01 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-11 |
13F-HR | 2022-02-10 |
13F-HR | 2021-11-12 |
13F-HR | 2021-08-16 |
View Amia Capital LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.